Concepedia

The Cost of Transplant Immunosuppressant Therapy: Is This Sustainable?

Alexandra James, Roslyn B. Mannon

Current Transplantation Reports · 2015 · 91 citations · 28 references

DOIFull text

Open access

Concepts

References

28

The price of innovation: new estimates of drug development costs

Joseph A. DiMasi, Ronald W. Hansen, Henry G. Grabowski · Journal of Health Economics · 2003 · 4.3K citations · Full text

, , +14

Pharmacotherapy: A Pathophysiologic Approach

Annals of Internal Medicine · 1989 · 2.4K citations

, , +12

A Phase III Study of Belatacept‐based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)

Flavio Vincenti, B Charpentier, Yves Vanrenterghem et al. · American Journal of Transplantation · 2010 · 946 citations

, , +15

Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants from Extended Criteria Donors (BENEFIT‐EXT Study)

Antoine Dürrbach, JO Medina Pestana, Thomas C. Pearson et al. · American Journal of Transplantation · 2010 · 565 citations · Full text

, , +17

SIROLIMUS ALLOWS EARLY CYCLOSPORINE WITHDRAWAL IN RENAL TRANSPLANTATION RESULTING IN IMPROVED RENAL FUNCTION AND LOWER BLOOD PRESSURE1,2,10

Robert W. Johnson, Henri Kreis, Rainer Oberbauer et al. · Transplantation · 2001 · 435 citations

, , +14